hotspot -WSS

hotspot

author：focus 2025-09-07 11:14:32 - browse：7

the Federal Trade Commission building and its brown sign — Adobe

A federal judge ordered Wednesday that Novant Health can move forward with its plan to buy two North Carolina hospitals, denying the Federal Trade Commission’s request for an injunction.

The FTC sued to block the deal in January, arguing that it would give Novant control of more than 65% of the region’s inpatient market. The case, one seeking to block nearby hospitals from merging and creating an even more powerful dominant player, is the FTC’s bread and butter. The agency has shied away from challenging cross-market and vertical mergers, but this one is right in its wheelhouse, which makes the setback surprising.

Under the deal, announced early last year, Novant would buy two hospitals in the same county from for-profit Community Health Systems for $320 million. The hospitals, Lake Norman Regional Medical Center and Davis Regional Medical Center, are only a 25-minute drive from one another. Davis Regional used to be a full-service hospital, but is now a psychiatric hospital. The deal also includes a group of 24 doctors, a majority interest in an endoscopy center, and a holding in a planned surgery center.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： FDA advisory panel to debate high blood pressure devices

knowledge

WSS

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

Why failed clinical trials don’t always spell doom for a new drug

Intellia plays down concerns on accidental germline transmission

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

FDA advisory panel to debate high blood pressure devices

California store owner shot dead in dispute over displaying Pride flag: Police

leisure time

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

knowledge

As demand for Covid shots wanes, Moderna seeks its next success

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

What does generative AI mean for health care? We asked experts

Former Pear Therapeutics executives start new VC firm

Dobbs anniversary: the lost opportunity of abortion as health care

Trans patients at the end of life deserve respect and dignity

23andMe had bad news about my health. I wish a person had delivered it

Why failed clinical trials don’t always spell doom for a new drug

Medical leaders decry Supreme Court decision on affirmative action

Emergent cuts jobs, executive role in business shake

focus

Can U.S. cancer drug shortages be fixed?

Maui's cultural, historic landmarks damaged in the devastating wildfires

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

As obesity drug market grows, telehealth companies court payers

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

Former Pear Therapeutics executives start new VC firm

hotspot

entertainment

knowledge

knowledge